🇺🇸 Polyamide in United States
34 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 34
Most-reported reactions
- Flushing — 5 reports (14.71%)
- Nausea — 4 reports (11.76%)
- Pyrexia — 4 reports (11.76%)
- Vomiting — 4 reports (11.76%)
- Asthenia — 3 reports (8.82%)
- Back Pain — 3 reports (8.82%)
- Chest Pain — 3 reports (8.82%)
- Malaise — 3 reports (8.82%)
- Pruritus — 3 reports (8.82%)
- Abdominal Pain — 2 reports (5.88%)
Other Other approved in United States
Frequently asked questions
Is Polyamide approved in United States?
Polyamide does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Polyamide in United States?
Universidad Científica del Sur is the originator. The local marketing authorisation holder may differ — check the official source linked above.